轻松健康集团今日暗盘上涨超110%，市值达百亿港元：明日正式登陆港交所

Core Viewpoint - The article highlights the upcoming IPO of Easy Health Group, emphasizing its significant growth driven by AI technology and its position in the digital health and insurance market in China [3][4]. Group 1: Company Overview - Easy Health Group plans to list on the Hong Kong Stock Exchange under the stock code "2661" [3]. - Established in 2014, Easy Health Group operates as a one-stop digital health and insurance service platform, with two main business pillars: digital comprehensive health services and digital comprehensive insurance services [4]. - As of June 30, 2025, the platform has 168 million registered users and approximately 59.7 million followers across various social media channels [4]. Group 2: Market Position - According to a report by Sullivan, Easy Health Group ranks 10th in China's digital comprehensive health and insurance service market based on projected 2024 revenue, and 7th in the digital health service market [4]. Group 3: User Demographics - Approximately 60.4% of users are aged between 20 and 45 years, indicating a younger user base that is likely to increase spending on health solutions as they experience life events such as marriage and childbirth [5]. - The younger demographic also presents significant upselling and cross-selling opportunities for the company [5]. Group 4: AI Technology Integration - AI technology is a crucial growth engine for Easy Health Group, with the proprietary AI technology stack, AIcare, serving as the core support for the platform [5]. - As of the last practical date, about 43.3% of the company's employees are involved in IT research and development [5]. - The company has registered 58 invention patents and 39 software copyrights related to its technological capabilities [5]. Group 5: Operational Efficiency - Easy Health Group has significantly improved operational efficiency and reduced costs through various technologies, including the Galaxy AI marketing platform, which has generated nearly 12.9 million business leads [6]. - The company has also launched generative AI tools, enhancing medical professionals' diagnostic and treatment capabilities [6]. Group 6: Financial Performance - Revenue figures for Easy Health Group from 2022 to 2024 are projected at 394 million, 490 million, and 945 million yuan, respectively, with a compound annual growth rate of 54.9% [6]. - In the first half of this year, the company's revenue grew by 84.7% year-on-year to 656 million yuan, with an adjusted net profit of 51.18 million yuan, reflecting an 11.3% increase [6]. Group 7: IPO Fund Utilization - The net proceeds from the IPO will primarily be used to enhance brand awareness, increase user engagement, strengthen partnerships, invest in medical research, improve AI and big data capabilities, expand into new regions and overseas markets, and for general corporate purposes [7].